Zafirlukast

NDC 31722-008 · Camber Pharmaceuticals, Inc.

Generic nameZafirlukast

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ZAFIRLUKAST

Strength20 mg/1

Pharmacologic classCytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]

Marketing categoryANDA

Packages

31722-008-01 — 10 BLISTER PACK in 1 CARTON (31722-008-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK

31722-008-05 — 500 TABLET, FILM COATED in 1 BOTTLE (31722-008-05)

31722-008-60 — 60 TABLET, FILM COATED in 1 BOTTLE (31722-008-60)

FDA lists these products with the same active ingredient.

31722-007 — Zafirlukast, 42291-970 — zafirlukast, 42291-971 — zafirlukast, 55111-625 — Zafirlukast, 55111-626 — Zafirlukast, 59651-291 — Zafirlukast, 59651-292 — Zafirlukast, 64380-187 — zafirlukast, 64380-188 — zafirlukast, 68084-059 — Zafirlukast, 72162-2361 — Zafirlukast

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.